In this study biopsies from skin lesions and draining lymph nodes of patients suffering from cutaneous leishmaniasis caused by Leishmania major were examined by immunohistochemistry, and by light and electron microscopy to identify the types of antigen-presenting cells (APC) and their location. APC, identified morphologically and by their expression of specific cell markers, included Langerhans cells, macrophages, follicular dendritic cells, and interdigitating reticulum cells of the paracortex of lymph nodes. These cells expressed MHC class II antigens and contained Leishmania antigen. Since some keratinocytes and endothelial cells also showed these characteristics, they may also act as APC. By examining tissue samples from skin lesions and draining lymph nodes it was possible to follow the probable route of trafficking of various inflammatory cells between the skin lesion and lymph nodes. Leishmania antigen containing Langerhans cells were found in the epidermis, dermis and the regional lymph nodes. We believe these cells translocate from the epidermis to the dermis, where they take up antigen and migrate to the paracortex of the regional lymph nodes. There they are intimately associated with cells of the paracortex, and could be involved in the generation of Leishmania-specific T memory cells. LFA-l-positive T cells of the CD45RO phenotype were found in the skin lesion. Venular endothelium in the skin lesions expressed intercellular adhesion molecule-I (ICAM-1), which is the ligand for LFA-1. The migration of lymphocytes from the vascular lumen to the site of inflammation is possibly a result of the interaction of these two adhesion molecules.
INTRODUCTION
Cutaneous leishmaniasis, due to Leishmania major, is endemic in many countries of the Middle East and Africa, including Saudi Arabia [1] and the Sudan [2] .
In most of those infected the disease is usually self-limiting, the lesions healing spontaneously, but some patients require treatment. Patients with healed lesions are usually immune to further infection by the same parasite. After healing they develop delayed hypersensitivity [3] . In vitro, this cell-mediated immune response is characterized by the production of interferon-gamma (IFN--y), and it can be described as a Thllike response [4] . The amastigote form of the parasite infects primarily the tissue macrophage where it multiplies until the macrophage is immunologically activated to kill the intracellular parasites. Activation of the macrophages is by the generation of T lymphocytes which secrete appropriate cytokines, particularly IFN--y, which enhance the killing capacity of the macrophage [5] . Another mechanism of parasite elimination is a necrotizing process in which the macrophage and the parasite it contains are destroyed, a poorly understood process in which immune complexes [6] or cytotoxic T cells may be involved [7] . Thus the generation of an appropriate immune response is crucial for parasite elimination. The afferent pathway in this response is dependent on the interaction between antigen-presenting cells (APC) and T lymphocytes. It is therefore worthwhile to define precisely the cells involved in this process and to monitor their trafficking in the lesion and draining lymph nodes. In this study we identify the APC as the epidermal Langerhans cells, macrophages, the interdigitating cells of the paracortex of lymph nodes and the follicular dendritic cells. The possible role of keratinocytes and endothelial cells in antigen presentation is discussed.
PATIENTS AND METHODS

Biopsy material for light microscopy and immunohistochemistry
Patients with cutaneous leishmaniasis were from an endemic focus in the Eastern Province of Saudi Arabia (n = 30) or the Sudan (n = 7). The disease is caused by Leishmania major in both countries [1, 8] , and the clinical and pathological features are the same in the two countries [9] . The diagnosis of cutaneous leishmaniasis was made by the demonstration of the parasites in skin biopsies and/or slit smears of the cutaneous lesion. The samples were collected after obtaining informed consent from the patients. The primary skin lesion was biopsied under local anaesthesia using a 4-mm disposable punch. Enlarged lymph nodes draining the skin lesions were removed surgically from two and eight patients from the Sudan and Saudi Arabia, respectively. Half of the material was embedded in OCT and snap frozen in liquid nitrogen. Frozen sections (5 pm) were cut with a cryostat and air dried overnight, before the immuno-staining. The other half of the tissue was fixed in mercuric chloride-acetic acid mixture for 15 h and was then transferred to 70% ethyl alcohol. Paraffin sections (5 Ism) were stained with haematoxylin and eosin. The histopathology of the lesion was classified according to Ridley [10] .
Immunohistochemistry
Biopsies from donors in Saudi Arabia were stained with anti-CD3, -CD4, -CD8, anti-HLA-DR antibodies (all from Becton Dickinson, Mountain View, CA). The staining procedure was according to the instructions provided by the manufacturer.
Briefly, cryostat-cut sections were fixed in cold acetone (40C) for 10min, air dried and transferred to PBS 05 M, pH7-4. Sections were incubated with 0 3% H202/methanol for 30 min to block endogenous peroxidase, followed by rinsing in water. The sections were then incubated with 1:2 normal goat serum for 30min to reduce non-specific staining. The primary antibodies were applied for 15min at 20'C. The sections were rewashed with PBS and exposed to biotinylated, goat antimouse IgG for 15 min at 20'C, and washed again in PBS. The sections were then exposed to avidin peroxidase for 15 min, washed in PBS and exposed to 3,3-diaminobenzidine-hydrogen peroxide mixture for 5 min. The sections were immersed in copper sulphate to enhance the colour, washed in PBS, lightly counter-stained with haematoxylin, dehydrated and mounted in distrene plasticizer xylene (DPX). The positive cells showed a distinct dark brown rim at the periphery of the cell and/or brown cytoplasmic staining. The number of T cells and subsets of T cells were estimated in these biopsies. At least five fields of the infiltrate with more than 40 cells in each focus were counted, as there was some variation in the cellular composition of individual infiltrates in different areas of the section. The number of CD3 + cells in a section was expressed as a percentage of the total number of cells in the infiltrate, and the number of CD4+ and CD8+ cells as a percentage of the total number of CD3 cells [11, 12] The biopsies from the Sudanese donors were stained with anti-CDla, -CD4, -CDl la (LFA-1), and -CD54 (intercellular adhesion molecule-I (ICAM)) antibodies (all from Dako, Glostrup, Denmark). The biotin avidin immunoperoxidase method with appropriate controls was used as described above. The immunoperoxidase-labelled primary antibodies against CD4 and CDla were visualized by 3-amino-9 ethyl carbazole, which gives a red colour, and those against LFA-1 and ICAM-1 markers were demonstrated by diamenobenzidine (DAB), which stains positive cells a dark brown colour. These biopsies were also double stained with anti-CD4, and anti-CD45RA or CD45RO [13] . The primary antibody against the CD4 molecule was visualized by DAB and the anti-CD45RO (memory T cells) or CD45RA (naive T cells) antibody was visualized by 3-amino-9 ethyl carbazole. Cells showing a brown reddish colour were considered double positive [13] .
Paraffin sections of formalin-fixed tissues from donors in Saudi Arabia were stained for lysozyme and an antibody against S-100 protein antigen using an immunoperoxidase kit (Ortho Diagnostic System Inc., Raritan, NJ) as previously described [14] . The total number of positive cells per five high power fields in a standard section were counted.
Demonstration of Leishmania antigen in the tissues Leishmania antigen was demonstrated by an indirect immunoperoxidase sandwich technique in tissue from donors in Saudi
Arabia. The method was based on that of Sells & Burton [15] . Sections were deparaffinized, brought to water and mounted on glass slides. Tris saline 0 05 M, pH 7-6 was used throughout the procedure as diluent and unless otherwise stated for washing. Staining was carried out in humidified chambers at room temperature. Anti-Leishmania sera were collected from BALB/c mice, which had been infected by 107 L. major stationary phase promastigotes [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] days previously. Sera were pooled from different mice and stored at -20°C. Serum was used in a dilution of 1:160. Normal mouse serum was similarly stored and diluted. Peroxidase-conjugated goat antimouse and normal goat serum were obtained from Dako. Endogenous peroxidase and non-specific binding of the antiLeishmania serum were blocked as described above. The anti-Leishmania serum was applied for 30min. After washing with buffer for 30 min the sections were incubated with peroxidase-conjugated goat anti-mouse serum at a dilution of 1:2 for 30min. This was followed by washing in buffer for 30min. DAB solution (Dako) was prepared according to the instructions of the manufacturer and the sections were incubated for 10min in the dark. Sections were then washed in tap water, lightly counter-stained with haematoxylin, dehydrated in alcohol and mounted in DPX. Controls included: (i) Tris buffer substituted for the peroxidase-conjugated serum; (ii) normal goat and absorbed anti-Leishmania serum. The absorbed serum was prepared by absorbing 0 5ml of antiLeishmania serum with 1010 live washed L. major promastigotes for 30min, after which the material was centrifuged at 500g for 10min and the supernatant was absorbed twice more with fresh promastigotes.
Indirect immunofluorescence for the detection of Leishmania antigen, in the skin and lymph nodes, was performed according to the method of Bray modified to detect Leishmania antigen in frozen sections [16] . Briefly, frozen sections were exposed to anti-Leishmania serum obtained from BALB/c mice characterized by focalized necrosis involving large numbers of parasitized macrophages, was found in seven biopsies. Eight lesions could not be fitted in the classification [10] . The pathology in this unclassified group showed mononuclear cells consisting of lymphocytes, plasma cells and macrophages. Irrespective of the histological type the venules had hypertrophied endothelium. The lymph nodes showed follicular hyperplasia with prominent germinal centres, the paracortex was expanded and the medulla contained many plasma cells.
Epithelioid granulomas were seen in five lymph nodes. In four of the nodes the granulomas showed central necrosis. These were negative for mycobacteria. Leishmania parasites were seen in four of the nodes and antigen was demonstrated by immunoperoxidase or immunofluorescence in all.
Distribution of APC Lysozyme-positive cells were found in the infiltrate of all histological types with a wide range of variation (Table 1) . They were most frequently seen in type B and C responses.
S-100 protein-positive cells were found in variable numbers within the infiltrate and the overlying epidermis irrespective of the histological type. In individual cases there was an inverse relation between the number of S-100-positive cells in the epidermis and that in the dermis. In one lesion suprabasal S-100-positive cells were dividing. An occasional positive cell was crossing the epidermo-dermal junction. The cells measured 10-17 pm and had large vesicular nuclei. In parallel sections the S-100-positive cells were always negative for lysozyme. The cells were scattered amongst the inflammatory cells in the dermis, and sometimes formed a rim around epithelioid granulomas.
Both lysozyme and S-100 protein-positive cells were found in the lymph nodes. The numbers varied considerably not only from one node to another but also with marked variation in different parts of the same node. Lysozyme-positive cells were found in the marginal sinus, the paracortex and occasionally in the follicles. S-100 protein-positive cells were seen in the afferent lymphatics, the marginal sinus and paracortex.
In order to substantiate further that cells with similar morphology and location as the S-100-positive cells were indeed Langerhans cell, tissues were stained by CDla, which is a marker for Langerhans cells in the skin [18] . Anti-CDlapositive cells were identified in the epidermis and in the dermal infiltrate of all the skin biopsies stained by anti-CDla (Fig. a) . Some were crossing the epidermo-dermal function. In the lymph nodes the anti-CDla-positive cells were found in the afferent lymphatics, the marginal sinus and the paracortex (Fig. lb) .
The presence of Langerhans cells in the epidermis and the dermal infiltrate was confirmed by electron microscopy by the demonstration of cells with Birbeck granules (data not shown). Parasitized and unparasitized macrophages, lymphocytes, and epithelioid cells were also identified in the infiltrate. Macrophages were in intimate contact with lymphocytes. Most of the cells in the dermis expressed MHC class II as 70-90% of the cells including some dendritic cells were HLA-DR-positive. The keratinocytes in the epidermis and hair follicles were also positive (Fig. 2) .
In the lymph nodes the high endothelial venules, the interdigitating reticulum cells, and the follicular dendritic cells were HLA-DR-positive.
Leishmania antigen in skin lesions and lymph nodes
In immunoperoxidase-stained sections parasites stained a brown colour and both nucleus and kinetoplast were identifiable. Antigen was identified in the cytoplasm and cell membrane of macrophages and in dendritic cells corresponding to the S-100 antigen-positive cells in the epidermis, dermis (Fig. 3a, b) , afferent lymphatics and paracortex. Follicular dendritic cells were also positive for Leishmania antigens. Immunofluorescence gave similar results to the immunoperoxidase. Control sections for both methods gave negative results.
ICAM-I and LFA-J expression on cells in the cutaneous lesion In the seven lesions examined the vascular endothelium gave a strong reaction for ICAM-1 (Fig. 4c) . Keratinocytes in and near the basal layer were also positive (Fig 4b) , and an occasional keratinocyte more superficially was weakly positive. In one biopsy a particularly strong ICAM-I expression on keratinocytes was associated with an infiltrate of LFA-1-positive mononuclear cells in the rete pegs. In another biopsy, there was a clear zone of dermis devoid of inflammatoty cells between the epidermis and an underlying inflammatory infiltrate. The keratinocytes overlaying this clear zone did not react with the ICAM-1 antibodies (Fig. 5a ).
In the infiltrate about 50% of the leucocytes were LFA-1-positive. Some LFA-1-positive cells were infiltrating the lower epidermis (Fig. 5b) . Scattered LFA-1-positive leucocytes were seen in the epidermis.
T cell phenotype in skin lesions and lymph nodes In skin biopsies from the 11 patients examined the CD3 + T cells formed between 18% and 79% (mean 50%) of the cells in the dermal infiltrate. The mean percentage of CD4+ cells and CD8+ cells was 56 5% (range 30-90%) and 43 5% (range 9-68%) of total T cells, respectively. Small numbers of both types of cells were seen in the epidermis, particularly in the basal layer.
In the lymph nodes most cells in the paracortex were CD3 + T cells with a preponderance of CD4' cells (70-80%) over CD8 + cells. The germinal centres contained small clusters of CD4 + cells and no CD8 + cells. DISCUSSION The role of macrophages in antigen presentation is well documented. We have found amastigotes and/or Leishmania antigen in lysozyme-positive macrophages in the cutaneous lesions and lymph nodes in the present and a previous study [14] . These cells also expressed MHC class II molecules and were in intimate contact with lymphocytes, when viewed under the electron microscope. Appropriately activated macrophages also function as effector cells in the elimination of intracellular parasites [19] . The other important APC in cutaneous leishmaniasis is the epidermal Langerhans cell [20] . This cell is a bone marrow-derived, dendritic cell that shares some features with the macrophage, such as surface expression of ATPase, non-specific esterase, receptors for complement and the Fc fragment of immunoglobulin [21] . Unlike macrophages it is lysozyme-negative, and expresses S-100 [14] and CDIa [21] .
Ultrastructurally it contains specific Birbeck granules and constitutively expresses MHC class II molecules [21] . Langerhans cells are poorly phagocytic but are potent stimulators of T cells in an antigen-specific and MHC-restricted manner [22] . They are recognized as the prominent APC of the skin [21] . It is believed that the cells pick up antigens from the epidermis and migrate from the epidermis to the regional lymph nodes draining the skin [21] . In the paracortex the Langerhans cells transform into interdigitating cells and present antigen to naive T cells [21] . In this study we have shown that Langerhans cells identified by the various markers are found in the infiltrate of the skin lesions of cutaneous leishmaniasis and in the draining lymph nodes. In the material from Saudi Arabia, Langerhans cells were demonstrated in the epidermis by the presence of S100-expressing cells. Since the S100-specific antibody also stains melanocytes, the S100 protein-positive cells in the basal layer may be Langerhans cells or melanocytes, whereas the positive cells in the suprabasal position of the epidermis are Langerhans cells. Using the specific CDla marker on the material from the Sudan, Langerhans cells were demonstrated in a suprabasal position in the epidermis, in the basal layer, and were found crossing the epidermo-dermal junction. A similar pattern was observed when S100 protein was used as a marker for the cells. In all the sites including the dermal infiltrate, the Langerhans cells contained Leishmania antigen and occasionally single parasites. The cells were traced to the regional lymph nodes, where they also contained Leishmania antigen. In the paracortex the cells were in intimate contact with the T cells. The presence of Leishmania antigen-containing Langerhans cells in the afferent lymphatics and the marginal sinus suggests that Langerhans cells take up antigen in skin lesions and migrate to the lymph nodes. This migratory pathway was recently shown to occur in BALB/c mice infected by L. major [23] . There was an inverse relationship between the numbers of Langerhans cells in the dermis and the epidermis, supporting the finding of Blank et al. [24] , who showed that in the murine model of L. major infection there was considerable loss of Langerhans cells in the segment of the epidermis overlying the parasite-containing infiltrate. This was taken to indicate that Langerhans cells migrate from the epidermis and pick up parasites from the dermis. The signals for the translocation of the Langerhans cells from the epidermis to the dermis may be mediated by IL-1,3 or tumour necrosis factor-alpha [20] .
The keratinocytes expressed HLA-DR and also contained Leishmania antigen, and thus may act as APC. Keratinocytes can phagocytose and digest extracellular debris, erythrocytes, Candida albicans [25] and killed whole Mycobacterium leprae [26] . They also produce cytokines that are similar to those released by various lymphoid cells [27] . We 
